The Association of the British Pharmaceutical Industry (ABPI) requires companies to annually document and publicly disclose transfers of value made to health professionals, other relevant decision makers, healthcare organisation, patient organisations and the public. This ensures greater transparency and high levels of trust between the UK patient community and the pharmaceutical industry. Flynn Pharma intends to support this process in full and commits to submitting all data in accordance with the instructions issued by the ABPI.